Actively Recruiting
Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Malignant Tumor
Led by Peking Union Medical College Hospital · Updated on 2025-08-05
50
Participants Needed
1
Research Sites
56 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
68Ga-DOTA-dPNE PET/CT imaging was performed on patients with malignant tumors to observe the binding of lesions with the tracer and evaluate the expression of CD73. At the same time, correlation analysis was performed combined with relevant clinical indicators to evaluate the efficacy of 68Ga-DOTA-dPNE in the diagnosis and guidance of malignant tumor patients, and predict the response of targeted therapy.
CONDITIONS
Official Title
Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Malignant Tumor
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older with expected survival of at least 12 weeks
- No recent radiotherapy or chemotherapy
- Surgery or biopsy feasible to obtain pathological diagnosis
- At least one measurable target lesion according to RECIST version 1.1
- Able to provide written informed consent and follow up
You will not qualify if you...
- Severe liver and kidney dysfunction
- Women planning to conceive, pregnant, breastfeeding, or planning pregnancy during the study; women of childbearing potential must use effective contraception throughout the study
- Unable to lie flat for thirty minutes
- Claustrophobia or other mental illnesses
- Other conditions deemed unsuitable by researchers
- Refusal to participate in the clinical study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
PUMCH
Dongcheng, Beijing Municipality, China, 100730
Actively Recruiting
Research Team
C
Chenhao Jia
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here